Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 6, 2011, Pages 456-461

  Abou Zeid, Abla A ^a   El Sayegh, Hesham K ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Gene expression; immunity; interleukins; kidney diseases; virology

Indexed keywords

BILIRUBIN; CREATININE; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN; TOLL LIKE RECEPTOR 3;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 3; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 80052960402     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.585660     Document Type: Article

References (33)

1. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91. (Pubitemid 30137669)
2. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009;16:650-8.
3. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006;43:915-22. (Pubitemid 43724616)
4. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 2006;8:53-9.
5. Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 2009;4:207-20.
6. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-80. (Pubitemid 32747155)
7. Alexopoulou, L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-KB by Toll-like receptor 3. Nature 2001;413:732-8. (Pubitemid 33009951)
8. Zarember KA, Godowski PJ. Tissue expression of toll-like receptors and differential regulation of toll-like receptor mRNAs in leucocytes in response to microbes, their products and cytokines. J Immunol 2002;168;554-61. (Pubitemid 34049553)
9. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002;169:2026-33. (Pubitemid 34857667)
10. Ebihara T, Shingai M, Matsumoto M, Wakita T, Seya T. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 2008;48:48-58. (Pubitemid 351975530)
11. Antonelli A, Ferri C, Ferrari SM, Ghiri E, Goglia F, Pampana A, Bruschi F, Fallahi P. Serum levels of proInflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum 2009;60:3841-7.
12. Targett-Adams P, Boulant S, McLauchlan J. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol 2008;82:2182-95. (Pubitemid 351293519)
13. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct tolllike receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 2006;12: 1198-204.
14. Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH. Changes in gene expression during peginterferon and ribavirin therapy of chronic hepatitis C distinguish responders from non responders to antiviral therapy. J Virol 2007;81:3391-401. (Pubitemid 46456648)
15. Wornle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Gröne HJ, Schlöndorff D. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006;16885.
16. Winfi eld JB, Koffl er D, Kunkel HG. Specifi c concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. J Clin Invest 1975;56:563-70.
17. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94. (Pubitemid 26388091)
18. Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, Kudesia G, El-Nahas AM. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002;17:239-45. (Pubitemid 34157137)
19. Cao Y, Zhang Y, Wang S, Zou W. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant 2009; 24:2745-51.
20. Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation 1998;65:741-4. (Pubitemid 28128949)
21. Coccoli R, Esposito R, Cianciaruso B, Pota A, Visciano B, Annecchini R, Parrilli G. Hepatitis C and kidney disease. Dig Liver Dis 2007;39(Suppl. 1):S83-5. (Pubitemid 47528197)
22. Unterholzner L, Bowie AG. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem Pharm 2008;75:589-602.
23. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ. APC-independent activation of NK cells by the Toll-like receptor 3 agonist doublestranded RNA. J Immunol 2004;172:138-43. (Pubitemid 38020465)
24. Atencia R, Bustamante FJ, Valdivieso A, Arrieta A, Rinon M, Prada A, Maruri N. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infectious Dis 2007; 7:136. doi:10.1186/1471-2334-7-136
25. Echeverria I, Zabaleta A, Silva L, Díaz-Valdés N, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Civeira MP, Prieto J, Sarobe P. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). J Viral Hepat 2008;15:782-9.
26. Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol 2008;80:980-8. (Pubitemid 351657008)
27. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L Jr, Mandrekar P, Zapp M, Szabo G. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-Inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003;170:5615-24. (Pubitemid 36617852)
28. Gale M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005;436:939-45. (Pubitemid 41191669)
29. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, Ikeda M, Gale M, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005;102:2992-7. (Pubitemid 40299904)
30. Alpers CE, Smith KD. Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens 2008;17:243-9. (Pubitemid 351535926)
31. Sabry A. Proteinuria among renal transplant patients and its relation to hepatitis C Virus and graft outcome: a single center experience. Exp Clin Transplant 2010;8:91-7.
32. Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol 2003;133:275-82.
33. Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 2008;21:813-25.